Firefly Neuroscience (NASDAQ: AIFF) Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform

Firefly Neuroscience provided a strategy update highlighting its commercially available Versus platform, a wireless dry-sensor EEG headset with interactive training software that has shipped more than 3,000 units and generates commercial revenue. Versus allows users to control flight and driving simulations through real-time brainwave activity, positioning Firefly in the human-performance segment of the emerging non-invasive BCI market.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.